Guidelines: AIOM Guidelines Compilation (Italy): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{forproviders}} | {{forproviders}} {{forpolicymakers}} | ||
Go back to [[Italy]] page | Go back to [[Italy]] page | ||
Revision as of 15:47, 3 September 2024
Go back to Italy page
Primary purpose: To improve and standardize clinical practice, offer the best care to patients nationwide, and provide evidence-based reference for national and regional institutions, regulatory bodies, and payers, with a focus on oncology and pain therapy in cancer patients.
Sponsor, manager or home institution: Associazione Italiana di Oncologia Medica (AIOM).
Type of information: diagnosis, primary tumour localization, tumour histology, tumour staging, comorbidities, risk of cancer, medical procedures, screening, palliative care, year.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.
